Skip to main content

Table 3 Cox regression of clinical outcome

From: New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins

  Univariable Multivariable
Hazard ratio (95% CI) p value Hazard ratio (95% CI) P-value
NODM
 Age 0.988 (0.976–1.000) 0.052   
 Male gender 1.307 (0.848–2.013) 0.225   
 Glucose 1.009 (1.006–1.011) < 0.001 1.009 (1.006–1.011) < 0.001
 Triglyceride 1.001 (1.000–1.002) 0.011 1.001 (1.000–1.002) 0.021
 β blocker 0.768 (0.517–1.139) 0.189   
 Statin type 1.098 (0.808–1.491) 0.551   
MACE
 Age 1.026 (1.016–1.037) < 0.001 1.020 (1.009–1.032) 0.001
 Male gender 0.964 (0.695–1.336) 0.824   
 LVEF 0.974 (0.961–0.986) < 0.001 0.980 (0.966–0.993) 0.003
 Glucose 1.003 (1.000–1.006) 0.089   
 Creatinine 1.155 (1.080–1.235) < 0.001 1.204 (1.062–1.364) 0.004
 LDL cholesterol 0.995 (0.992–0.999) 0.011 0.998 (0.994–1.002) 0.258
 Statin type 0.944 (0.727–1.225) 0.662   
 Ticagrelor or prasugrel 0.685 (0.522–0.899) 0.006 0.784 (0.585–1.051) 0.104
 ACEi or ARB 0.761 (0.569–1.018) 0.066   
β blocker 0.855 (0.609–1.201) 0.367   
  1. ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, LDL low-density lipoprotein, LVEF left ventricle ejection fraction